Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00972413 · ClinicalTrials.gov registry record · Phase 1
Cone Beam Computed Tomography for Breast Imaging
A Phase 1 study of Breast Cancer, sponsored by Koning Corporation.
- Completed
- Registry status
- Phase 1
- Development phase
- 104
- Enrollment target
- 1
- Study location
NCT00972413: Completed Phase 1 study of Breast Cancer, sponsored by Koning Corporation.
NCT00972413 is a Phase 1 study of Breast Cancer that has completed, run by Koning Corporation. The registered enrollment target is 104 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00972413, a Phase 1 study of Breast Cancer, has completed, sponsored by Koning Corporation.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 104 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary aim of this study is to investigate the use of cone beam computed tomography (CBCT) for breast imaging in the diagnostic setting by providing a compelling body of evidence incorporating both non-contrast and contrast enhanced CBCT in the study protocol. The goal is to accumulate a body of evidence to provide data to incorporate CBCT into the diagnostic work-up of breast lesions.
Conditions Studied
Interventions
- RADIATION Computed Tomography
Study Locations (1)
New York
- Elizabeth Wende Breast Care - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 104 participants |
| Start Date | 2008-06 |
| Est. Completion | 2012-05 |
| Phase | Phase 1 |
What the finished NCT00972413 record still lists
NCT00972413 is an interventional study that assigns participants to a tested intervention. The registered 104 participants enrollment target is mid-sized for trials with a published cap, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Computed Tomography is the first listed.
NCT00972413 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT00972413 about?
NCT00972413 is a clinical study titled "Cone Beam Computed Tomography for Breast Imaging". The primary aim of this study is to investigate the use of cone beam computed tomography (CBCT) for breast imaging in the diagnostic setting by providing a compelling body of evidence incorporating both non-contrast and contrast enhanced CBCT in the study protocol. The goal is to accumulate a body o...
What is the current status of trial NCT00972413?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 104 participants. The study started on 2008-06. Estimated completion is 2012-05.
What conditions does trial NCT00972413 study?
This clinical trial studies the following conditions: Breast Cancer.
What interventions are being tested in trial NCT00972413?
The interventions under investigation include: Computed Tomography (RADIATION).
Who is sponsoring clinical trial NCT00972413?
This trial is sponsored by Koning Corporation, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00972413 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00972413's enrollment target sits among peer trials
104 553rd of 1224 higher than 669 of 1,224 other Breast Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
VS-6766+Abema+Fulv in Met HR+/HER- BC
RECRUITING · Phase 1
-
KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung Cancer
RECRUITING · Phase 1
-
Focused Ultrasound and Gemcitabine in Breast Cancer
RECRUITING · Phase 1
-
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
RECRUITING · Phase 1
-
Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
RECRUITING · Phase 1
-
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03403686 · 104 participants
Liver X Receptor (LXR) as a Novel Therapeutic Target in Diabetic Retinopathy (DR)
- NCT04228367 · 104 participants · NA
JuggerStitch Post Market Clinical Follow-up Study
- NCT04268849 · 104 participants · Phase 3
Trial of IV vs Oral Iron Treatment of Iron Deficiency Anemia in the Post-Operative Bariatric Surgical Patient
- NCT04390724 · 104 participants
Optimizing Y90 Therapy for Radiation Lobectomy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia